Treza12/datasetonePTBXL · Datasets at Hugging Face

subfolder stringclasses 22 values	prompt stringlengths 304 306	image imagewidth (px) 1k 1k
16000	ECG signal from 16000/16531_hr, V1, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
16000	ECG signal from 16000/16531_hr, V2, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
16000	ECG signal from 16000/16531_hr, V3, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
16000	ECG signal from 16000/16531_hr, V4, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
16000	ECG signal from 16000/16531_hr, V5, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
16000	ECG signal from 16000/16531_hr, V6, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
16000	ECG signal from 16000/16612_hr, I, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
16000	ECG signal from 16000/16612_hr, II, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
16000	ECG signal from 16000/16612_hr, III, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
16000	ECG signal from 16000/16612_hr, AVR, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
16000	ECG signal from 16000/16612_hr, AVL, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
16000	ECG signal from 16000/16612_hr, AVF, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
16000	ECG signal from 16000/16612_hr, V1, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
16000	ECG signal from 16000/16612_hr, V2, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
16000	ECG signal from 16000/16612_hr, V3, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
16000	ECG signal from 16000/16612_hr, V4, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
16000	ECG signal from 16000/16612_hr, V5, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
16000	ECG signal from 16000/16612_hr, V6, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
16000	ECG signal from 16000/16450_hr, I, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
16000	ECG signal from 16000/16450_hr, II, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
16000	ECG signal from 16000/16450_hr, III, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
16000	ECG signal from 16000/16450_hr, AVR, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
16000	ECG signal from 16000/16450_hr, AVL, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
16000	ECG signal from 16000/16450_hr, AVF, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
16000	ECG signal from 16000/16450_hr, V1, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
16000	ECG signal from 16000/16450_hr, V2, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
16000	ECG signal from 16000/16450_hr, V3, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
16000	ECG signal from 16000/16450_hr, V4, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
16000	ECG signal from 16000/16450_hr, V5, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
16000	ECG signal from 16000/16450_hr, V6, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
16000	ECG signal from 16000/16889_hr, I, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
16000	ECG signal from 16000/16889_hr, II, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
16000	ECG signal from 16000/16889_hr, III, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
16000	ECG signal from 16000/16889_hr, AVR, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
16000	ECG signal from 16000/16889_hr, AVL, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
16000	ECG signal from 16000/16889_hr, AVF, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
16000	ECG signal from 16000/16889_hr, V1, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
16000	ECG signal from 16000/16889_hr, V2, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
16000	ECG signal from 16000/16889_hr, V3, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
16000	ECG signal from 16000/16889_hr, V4, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
16000	ECG signal from 16000/16889_hr, V5, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
16000	ECG signal from 16000/16889_hr, V6, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
16000	ECG signal from 16000/16171_hr, I, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
16000	ECG signal from 16000/16171_hr, II, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
16000	ECG signal from 16000/16171_hr, III, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
16000	ECG signal from 16000/16171_hr, AVR, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
16000	ECG signal from 16000/16171_hr, AVL, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
16000	ECG signal from 16000/16171_hr, AVF, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
16000	ECG signal from 16000/16171_hr, V1, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
16000	ECG signal from 16000/16171_hr, V2, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
16000	ECG signal from 16000/16171_hr, V3, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
16000	ECG signal from 16000/16171_hr, V4, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
16000	ECG signal from 16000/16171_hr, V5, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
16000	ECG signal from 16000/16171_hr, V6, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
16000	ECG signal from 16000/16333_hr, I, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
16000	ECG signal from 16000/16333_hr, II, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
16000	ECG signal from 16000/16333_hr, III, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
16000	ECG signal from 16000/16333_hr, AVR, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
16000	ECG signal from 16000/16333_hr, AVL, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
16000	ECG signal from 16000/16333_hr, AVF, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
16000	ECG signal from 16000/16333_hr, V1, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
16000	ECG signal from 16000/16333_hr, V2, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
16000	ECG signal from 16000/16333_hr, V3, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
16000	ECG signal from 16000/16333_hr, V4, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

16000

ECG signal from 16000/16531_hr, V1, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

16000

ECG signal from 16000/16531_hr, V2, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

16000

ECG signal from 16000/16531_hr, V3, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

16000

ECG signal from 16000/16531_hr, V4, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

16000

ECG signal from 16000/16531_hr, V5, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

16000

ECG signal from 16000/16531_hr, V6, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

16000

ECG signal from 16000/16612_hr, I, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

16000

ECG signal from 16000/16612_hr, II, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

16000

ECG signal from 16000/16612_hr, III, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

16000

ECG signal from 16000/16612_hr, AVR, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

16000

ECG signal from 16000/16612_hr, AVL, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

16000

ECG signal from 16000/16612_hr, AVF, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

16000

ECG signal from 16000/16612_hr, V1, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

16000

ECG signal from 16000/16612_hr, V2, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

16000

ECG signal from 16000/16612_hr, V3, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

16000

ECG signal from 16000/16612_hr, V4, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

16000

ECG signal from 16000/16612_hr, V5, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

16000

ECG signal from 16000/16612_hr, V6, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

16000

ECG signal from 16000/16450_hr, I, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

16000

ECG signal from 16000/16450_hr, II, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

16000

ECG signal from 16000/16450_hr, III, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

16000

ECG signal from 16000/16450_hr, AVR, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

16000

ECG signal from 16000/16450_hr, AVL, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

16000

ECG signal from 16000/16450_hr, AVF, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

16000

ECG signal from 16000/16450_hr, V1, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

16000

ECG signal from 16000/16450_hr, V2, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

16000

ECG signal from 16000/16450_hr, V3, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

16000

ECG signal from 16000/16450_hr, V4, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

16000

ECG signal from 16000/16450_hr, V5, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

16000

ECG signal from 16000/16450_hr, V6, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

16000

ECG signal from 16000/16889_hr, I, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

16000

ECG signal from 16000/16889_hr, II, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

16000

ECG signal from 16000/16889_hr, III, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

16000

ECG signal from 16000/16889_hr, AVR, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

16000

ECG signal from 16000/16889_hr, AVL, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

16000

ECG signal from 16000/16889_hr, AVF, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

16000

ECG signal from 16000/16889_hr, V1, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

16000

ECG signal from 16000/16889_hr, V2, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

16000

ECG signal from 16000/16889_hr, V3, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

16000

ECG signal from 16000/16889_hr, V4, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

16000

ECG signal from 16000/16889_hr, V5, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

16000

ECG signal from 16000/16889_hr, V6, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

16000

ECG signal from 16000/16171_hr, I, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

16000

ECG signal from 16000/16171_hr, II, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

16000

ECG signal from 16000/16171_hr, III, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

16000

ECG signal from 16000/16171_hr, AVR, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

16000

ECG signal from 16000/16171_hr, AVL, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

16000

ECG signal from 16000/16171_hr, AVF, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

16000

ECG signal from 16000/16171_hr, V1, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

16000

ECG signal from 16000/16171_hr, V2, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

16000

ECG signal from 16000/16171_hr, V3, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

16000

ECG signal from 16000/16171_hr, V4, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

16000

ECG signal from 16000/16171_hr, V5, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

16000

ECG signal from 16000/16171_hr, V6, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

16000

ECG signal from 16000/16333_hr, I, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

16000

ECG signal from 16000/16333_hr, II, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

16000

ECG signal from 16000/16333_hr, III, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

16000

ECG signal from 16000/16333_hr, AVR, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

16000

ECG signal from 16000/16333_hr, AVL, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

16000

ECG signal from 16000/16333_hr, AVF, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

16000

ECG signal from 16000/16333_hr, V1, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

16000

ECG signal from 16000/16333_hr, V2, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

16000

ECG signal from 16000/16333_hr, V3, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

16000

ECG signal from 16000/16333_hr, V4, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.